May 15, 2020
Moving Beyond 'Lives-Saved' From COVID-19
This blog covers the presentation given as part of the ISPOR pre-conference plenary session on HEOR in the era of COVID-19 which was held on 14 May 2020.
-
-
May 11, 2020Economic Cycles and Product Development in Life Sc...Economic Cycles and Product Development in Life Sciences May 11, 2020 By John Schneider, PhD and Mirela Sima, MD, MBA The humanistic and economic consequences of the 2020 COVID-19 pandemic wi... -
May 5, 2020Avalon’s Andrew Briggs Conducted Work on the Exces...The Wall Street Journal recently covered the work that Avalon’s Andrew Briggs conducted on the excess mortality attributable to COVID-19. Briggs put the U.S. average at almost 14 years lost and the U.... -
April 29, 2020Cost Impact Model of a Novel Multi-mRNA Host Respo...The Avalon team helped Inflammatix, Inc., develop economic evidence for HostDx Sepsis test for the diagnosis of acute infections. A newly released publication describes a cost impact model comparing t... -
April 27, 2020Electronic Medical Records: Potential Issues in Li...In this blog entry we explore some of the potentially important issues surrounding the role of EMRs in litigation, where the discovery of medical documents and records increasing involves digitally st... -
April 17, 2020Estimating QALY Losses Associated With Deaths in H...Avalon Director Andrew Briggs, DPhil, addresses the issue of potential losses in quality-adjusted life years (QALYs) associated with COVID-19.
-
April 17, 2020Applications of HEOR Analytics: Covariate-Adjusted...In this blog entry we report on a good example of HEOR analytics: our recent study of covariate-adjusted analysis of trial data of lenvatinib versus sorafenib in hepatocellular carcinoma. -
April 14, 2020COVID-19: Update on Epidemiology & CostsWe define epidemiology broadly, including an up-to-date review of the key published medical literature on COVID-19. Following that, our discussion of costs focuses in part on the direct medical costs ... -
April 8, 2020Distinguishing Between Viral and Bacterial Respira...Avalon researchers published important research on distinguishing between viral and bacterial respiratory infections, a topic that is of great importance given the COVID-19 pandemic. Check out the stu... -
March 13, 2020The Coronavirus: How Bad is it, Really?By: The Avalon Health Economics Team March 13, 2020 Within a few months we’ve gone from worrying about holiday shopping to worrying about global pandemics and watching the world shut down ar... -
February 10, 2020What is the Reasonable Value of Future Medical Car...Cara Scheibling and John Schneider, PhD February 7, 2020 A common challenge in economics and business is determining the fair-market value of products and services that have not yet “e... -
December 23, 2019How Important is ICER Preparation and Review for U...John Schneider, PhD and Alexis Doyle, MA Avalon Health Economics December 23, 2019 In recent years in the U.S., there has been an increase in the use of cost-effectiveness analysis (CEA) fo... -
October 16, 2019Avalon Health Economics Will Be At ISPOR Copenhage...Avalon Health Economics will be at ISPOR Copenhagen November 2nd-6th. Let us know if you will be there and want to set up a meeting! For more information, please visit the ISPOR website. -
September 16, 2019New HEOR Publication: Monitoring Technology for Se...Economic evaluation of passive monitoring technology for seniors 2019 By John E. Schneider, Jacie Cooper. Cara Scheibling, and Anjani Parikh Abstract: By 2050, the global population of persons... -
August 27, 2019Avalon & Oberender Enter a New CollaborationAvalon Health Economics has entered into a collaborative agreement with Oberender, a leading global healthcare management consultancy based in Germany. The agreement allows Av... -
July 17, 2019Using Payer Research to Assess Medical Device Mark...This blog is written by John Schneider, PhD, Sabrina Chmelir, Jacie Cooper, and Shawn Davies, MA Advances in technological innovation and access to capital have recently resulted in a wave o... -
June 20, 2019Optometry’s Essential and Expanding Role in Health...This research summary is written by John E. Schneider, PhD & Cara M. Scheibling A two-decade drumbeat of bold, future-focused and entirely bi-partisan changes in U.S. state laws has ush... -
June 19, 2019Healthcare Use Cases for Blockchain TechnologyThis blog was written by John Schneider, PhD, Katherine Dick, Cara Scheibling Recently, the crypto-currency company Bitcoin has been in the news, mainly for its combination of volatility in valuation... -
June 10, 2019Smoke, Mirrors, and Wild Geese: What Should Be the...Andrew Briggs, DPhil Chair of Health Economics, University of Glasgow, Glasgow UK. Senior Scientist, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Director and Principa... -
March 14, 2019Avalon Health Economics will be at ISPOR New Orlea...Avalon Health Economics will be at ISPOR New Orleans, May 18 through May 22. We will be engaged in our usual array of posters, podium presentations, and short courses. If you are planning on attending... -
December 26, 2018Avalon Health Economics Collaborates with Acaster-...Avalon Health Economics is happy to announce an exciting new collaboration with the London-based Acaster-Lloyd Consulting, Ltd. Acaster-Lloyd, led by Sarah Acaster and Andrew Lloyd, is a leader in the...
